Apyx Medical Corp expected to post a loss of 20 cents a share - Earnings Preview

Apyx Medical

07/08/2024 03:04

* Apyx Medical Corp  APYX.OQ   APYX.O  is expected to show a
fall
in quarterly revenue when it reports  results on August 8 for
the period ending June 30 2024
    * The Clearwater Florida-based  company is expected to
report a
13.4% decrease in revenue to $11.747 million from $13.57 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Apyx Medical Corp is for
a
loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Apyx
Medical Corp
is $2.25​, above​ its last closing price of $1.03. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.22       -0.21      -0.22     Missed  -2.6
 Dec. 31 2024  -0.20       -0.18      -0.28     Missed  -57.7
 Sep. 30 2023  -0.12       -0.11      -0.13     Missed  -14.8​
 Jan. 1 0001   -0.07       -0.07      -0.11     Missed  -58.5
 ​​Mar.        -0.16                  -0.10             25.9
 31 2023                                                
 Jan. 1 0001   -0.15       -0.14      -0.17     Missed  -19.3​
 Jun. 30 2022  -0.15       -0.14      -0.17     Missed  -17.2
 Jun. 30 2022  -0.19       -0.19      -0.16     Beat    14.7
 This summary was machine generated August 7 at 02:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)